Skip to main content
. 2012 Aug;56(8):4495–4499. doi: 10.1128/AAC.06396-11

Fig 1.

Fig 1

QTc intervals in 6 patients who received intravenous quinidine for management of resistant malaria or babesiosis. ■, patient 1; ●, patient 2; ▲, patient 3; ▼, patient 4; ♦, patient 5; ◀, patient 6. Note that patients 3 and 4 developed torsades de pointes.